Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer

This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer.

Detalles Bibliográficos
Autores principales: Brant, Aaron, Lewicki, Patrick, Xiang, Michael, Zhu, Alec, Kishan, Amar U., Pollom, Erqi Liu, Shoag, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468886/
https://www.ncbi.nlm.nih.gov/pubmed/36094506
http://dx.doi.org/10.1001/jamanetworkopen.2022.31101
Descripción
Sumario:This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer.

Ejemplares similares